Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.

about

Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.

Item

http://www.wikidata.org/entity/Q47575865

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.

@en

Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.

@nl

type

Item

label

Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.

@en

Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.

@nl

prefLabel

Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.

@en

Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.

@nl

P1476

Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors.

@en

P2093

Chin-Ho Chen

http://www.w3.org/2001/XMLSchema#string

Hua Xie

http://www.w3.org/2001/XMLSchema#string

Lei Zhu

http://www.w3.org/2001/XMLSchema#string

Li Huang

http://www.w3.org/2001/XMLSchema#string

Qingye Zhang

http://www.w3.org/2001/XMLSchema#string

Zhao Dang

http://www.w3.org/2001/XMLSchema#string

Zhijun Li

http://www.w3.org/2001/XMLSchema#string

P2860

Privileged scaffolds for library design and drug discovery

Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer

Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the betulinic acid derivative IC9564

A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion

Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.

Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.

Picomolar dichotomous activity of gnidimacrin against HIV-1.

HIV entry and envelope glycoprotein-mediated fusion

Bifunctional anti-human immunodeficiency virus type 1 small molecules with two novel mechanisms of action.

HIV-1 antiretroviral drug therapy.

P304

1199-1203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.7B00376

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29152054

http://www.w3.org/2001/XMLSchema#string

P932

5683702

http://www.w3.org/2001/XMLSchema#string